Your browser doesn't support javascript.
loading
Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension.
Furukawa, Asuka; Tamura, Yuichi; Iwahori, Hiroya; Goto, Masato; Ohashi, Narutaka; Okabe, Teruo; Kawamura, Akio.
Afiliación
  • Furukawa A; Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital, 1-4-3, Mita, Minatoku, Tokyo, Japan.
  • Tamura Y; Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital, 1-4-3, Mita, Minatoku, Tokyo, Japan. u1@ta-mu.net.
  • Iwahori H; Department of Cardiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
  • Goto M; Department of Cardiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
  • Ohashi N; Department of Cardiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
  • Okabe T; Department of Cardiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
  • Kawamura A; Department of Cardiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
BMC Pulm Med ; 17(1): 135, 2017 Oct 26.
Article en En | MEDLINE | ID: mdl-29073911

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirazinas / Epoprostenol / Hipertensión Pulmonar Primaria Familiar / Acetamidas / Antihipertensivos Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: BMC Pulm Med Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirazinas / Epoprostenol / Hipertensión Pulmonar Primaria Familiar / Acetamidas / Antihipertensivos Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: BMC Pulm Med Año: 2017 Tipo del documento: Article